Current prospects for RNA interference-based therapies

作者: Beverly L. Davidson , Paul B. McCray

DOI: 10.1038/NRG2968

关键词:

摘要: RNA interference (RNAi) is a powerful approach for reducing expression of endogenously expressed proteins. It widely used biological applications and being harnessed to silence mRNAs encoding pathogenic proteins therapy. Various methods — including delivering oligonucleotides expressing RNAi triggers from viral vectors have been developed successful in cell culture vivo. Recently, RNAi-based gene silencing approaches demonstrated humans, ongoing clinical trials hold promise treating fatal disorders or providing alternatives traditional small molecule therapies. Here we describe the broad range achieve targeted therapy, discuss important considerations when developing use review current status trials.

参考文章(166)
Adam D. Judge, Marjorie Robbins, Iran Tavakoli, Jasna Levi, Lina Hu, Anna Fronda, Ellen Ambegia, Kevin McClintock, Ian MacLachlan, Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. Journal of Clinical Investigation. ,vol. 119, pp. 661- 673 ,(2009) , 10.1172/JCI37515
R. A. Klinghoffer, J. Magnus, J. Schelter, M. Mehaffey, C. Coleman, M. A. Cleary, Reduced seed region-based off-target activity with lentivirus-mediated RNAi RNA. ,vol. 16, pp. 879- 884 ,(2010) , 10.1261/RNA.1977810
Sang-Soo Kim, Dan Peer, Priti Kumar, Sandesh Subramanya, Huaquan Wu, Deshratan Asthana, Katsuyoshi Habiro, Yong-Guang Yang, N Manjunath, Motomu Shimaoka, Premlata Shankar, RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Molecular Therapy. ,vol. 18, pp. 370- 376 ,(2010) , 10.1038/MT.2009.271
Thomas W Geisbert, Amy CH Lee, Marjorie Robbins, Joan B Geisbert, Anna N Honko, Vandana Sood, Joshua C Johnson, Susan de Jong, Iran Tavakoli, Adam Judge, Lisa E Hensley, Ian MacLachlan, Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study The Lancet. ,vol. 375, pp. 1896- 1905 ,(2010) , 10.1016/S0140-6736(10)60357-1
Peggy Marconi, Rafaela Argnani, Alberto L. Epstein, Roberto Manservigi, HSV as a Vector in Vaccine Development and Gene Therapy Pharmaceutical Biotechnology. ,vol. 655, pp. 118- 144 ,(2009) , 10.1007/978-1-4419-1132-2_10
Michiro Susa, Arun K. Iyer, Keinosuke Ryu, Edwin Choy, Francis J. Hornicek, Henry Mankin, Lara Milane, Mansoor M. Amiji, Zhenfeng Duan, Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma PLoS ONE. ,vol. 5, pp. e10764- ,(2010) , 10.1371/JOURNAL.PONE.0010764
B Geusens, N Sanders, T Prow, M Van Gele, J Lambert, Cutaneous short-interfering RNA therapy Expert Opinion on Drug Delivery. ,vol. 6, pp. 1333- 1349 ,(2009) , 10.1517/17425240903304032
Y. P. Liu, M. A. Vink, J.-T. Westerink, E. Ramirez de Arellano, P. Konstantinova, O. Ter Brake, B. Berkhout, Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies. RNA. ,vol. 16, pp. 1328- 1339 ,(2010) , 10.1261/RNA.1887910
Jose M Silva, Mamie Z Li, Ken Chang, Wei Ge, Michael C Golding, Richard J Rickles, Despina Siolas, Guang Hu, Patrick J Paddison, Michael R Schlabach, Nihar Sheth, Jeff Bradshaw, Julia Burchard, Amit Kulkarni, Guy Cavet, Ravi Sachidanandam, W Richard McCombie, Michele A Cleary, Stephen J Elledge, Gregory J Hannon, Second-generation shRNA libraries covering the mouse and human genomes Nature Genetics. ,vol. 37, pp. 1281- 1288 ,(2005) , 10.1038/NG1650